Farxiga (dapagliflozin) has a half-life of roughly 12.9 hours, meaning the drug is essentially cleared from your bloodstream within about 3 days of your last dose. Its effects on your body, particularly increased sugar in the urine, follow a similar timeline, though in some cases those effects can linger longer.
How the Drug Leaves Your Body
A drug’s half-life tells you how long it takes for your body to eliminate half of a single dose. With Farxiga’s half-life of approximately 12.9 hours, the amount in your blood drops by half roughly every 13 hours. After five half-lives, about 65 hours or just under 3 days, the drug is considered fully cleared from your system. This lines up with FDA labeling: after stopping the 10 mg dose, the excess glucose appearing in urine returns to baseline levels in about 3 days on average.
Your liver does most of the work breaking Farxiga down. The drug is primarily converted into an inactive form that no longer blocks sugar reabsorption in the kidneys. The inactive metabolites are then excreted through both urine and stool.
When Effects Can Last Longer Than Expected
While 3 days is the average clearance window, it is not universal. Post-marketing reports collected by the FDA describe cases where increased urinary glucose and, more concerning, ketoacidosis persisted for longer than 6 days after stopping an SGLT2 inhibitor like Farxiga. Some cases lasted up to 2 weeks. These are not typical, but they are documented.
This extended activity is one reason the drug’s surgical guidelines build in a buffer. The American Diabetes Association recommends stopping Farxiga at least 3 days before any scheduled surgery. The concern is a rare complication called euglycemic ketoacidosis, where dangerous acid levels build up in the blood even though blood sugar readings look normal. The 3-day window gives the drug enough time to clear in most people, reducing that risk while you are under anesthesia and unable to eat or drink normally.
Factors That Slow Clearance
Several things can affect how quickly your body processes and eliminates Farxiga.
Age. Adults over 65 carry about 1.3 times more of the drug in their bloodstream compared to adults aged 25 to 65, based on FDA pharmacology reviews. That difference is modest and does not require a dose change, but it means older adults may take slightly longer to fully clear the medication. Younger adults and adolescents process the drug at roughly the same rate as middle-aged adults.
Liver function. Because the liver is Farxiga’s primary breakdown site, impaired liver function raises drug levels. In people with mild to moderate liver problems, peak blood levels and overall drug exposure increase by up to 22% and 36%, respectively. In people with severe liver disease, those numbers climb to 40% and 67%. Even in the most severe cases, though, total exposure stays below double the normal amount, which the FDA considers within a safe margin. No dose adjustment is required for liver impairment alone.
Kidney function. Reduced kidney function changes how effectively Farxiga works (it relies on filtering sugar through the kidneys), but the drug itself is not primarily cleared by the kidneys. So while kidney disease alters the medication’s effectiveness, it has a smaller impact on how long Farxiga physically remains in your blood.
Why Clinical Trials Use Longer Washout Periods
If Farxiga clears the blood in about 3 days, you might wonder why clinical trials sometimes wait much longer between treatment phases. In the DIAMOND trial studying dapagliflozin in chronic kidney disease, researchers used a 6-week washout period between treatment rounds. This extended window is not about waiting for the drug molecule to leave the body. It accounts for the downstream biological changes Farxiga causes, things like shifts in kidney filtration, blood pressure, and fluid balance, which take additional weeks to fully reverse. Researchers want a clean baseline before starting the next phase, so they build in a generous margin.
For practical purposes, the drug itself is gone in roughly 3 days. But the broader metabolic adjustments your body made while on the medication may take a few weeks to fully normalize, which is worth knowing if you are transitioning to a different treatment.
Practical Takeaways for Stopping Farxiga
If you are stopping Farxiga for surgery, the 3-day-before rule is the standard guideline. If you are stopping for other reasons, the drug will be out of your bloodstream within about 3 days in most cases, with its effects on urinary glucose fading over the same window. Stay aware that in uncommon situations, residual effects can persist beyond a week. Staying hydrated and monitoring for symptoms like nausea, abdominal pain, or unusual fatigue during the days after stopping is a reasonable precaution, as these can signal ketoacidosis even when blood sugar appears normal.